Summary & Overview
HCPCS Level II Q4418: Biolab Membrane Wrap, Per Square Centimeter
HCPCS Level II code Q4418 designates a biolab membrane wrap flow, billed per square centimeter as an add-on to a primary surgical or procedural service. This code matters nationally because it captures incremental supply costs and resource utilization when biologic membrane products are used to support tissue repair, wound coverage, or reconstruction — items that can significantly affect episode costs and clinical documentation requirements. Key payers considered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare.
Readers will learn what Q4418 represents clinically and operationally, how it is used as an add-on supply code, and where it is typically applied (operating rooms and procedure suites). The publication provides benchmarks and contextual information useful for billing teams and revenue cycle managers, outlines common documentation expectations for add-on biologic supplies, and summarizes relevant policy considerations and coding practice implications for national payers. Data not available in the input is noted where payer-specific coverage or modifier guidance is not provided.
Billing Code Overview
HCPCS Level II code Q4418 describes a biolab membrane wrap flow, billed per square centimeter as an add-on. This code is used when a membrane wrap product is applied in conjunction with a primary procedure and is reported separately from the main service.
Service type: biologic membrane placement (add-on)
Typical site of service: operating room or procedure suite, where membrane wraps are applied during surgical or procedural interventions involving tissue repair or reconstruction.
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult with a chronic, non-healing wound (for example, a diabetic foot ulcer or a complex surgical wound) requiring advanced biologic wound care. After initial debridement and wound bed preparation in an outpatient wound clinic or hospital setting, the clinician measures the wound area and applies a biolab membrane wrap product to the defect. The membrane is used as an adjunctive topical biologic dressing to promote granulation and barrier protection and is billed as an add-on per square centimeter using Q4418 in addition to a primary wound procedure or debridement service. Billing commonly occurs after documentation of wound characteristics (size, depth, exudate, infection status), procedure notes confirming membrane selection and placement, and photographic or measurement evidence of the square-centimeter area treated. Typical sites of service include outpatient wound centers, hospital outpatient departments, ambulatory surgical centers, and skilled nursing facilities when advanced wound care is provided.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
25 | Significant, separately identifiable evaluation and management service by the same physician on the day of a procedure | When an E/M visit distinct from the wound procedure is performed and documented on the same day as Q4418 billing |